An unfavourable environment weighs on OTSUKA HOLDINGS, which sees a downgrade to Slightly Negative
The independent financial analyst theScreener just requalified the general evaluation of OTSUKA HOLDINGS (JP), active in the Pharmaceuticals industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date July 27, 2021, the closing price was JPY 4,487.00 and its target price was estimated at JPY 3,970.16.Otsuka Holdings is a pharmaceutical holding company. Co. operates in four business segments. Pharmaceutical segment is engaged in the sale of ethical pharmaceutical; the manufacture, sale and export of curative medicine; as well as the research and development of pharmaceutical products. Nutraceuticals segment manufactures, purchases and sells functional beverages and foods. Consumer Products segment manufactures and sells consumer products and mineral water. Others segment is involved in the manufacture and sale of chemical products; the manufacture, import and sale of measurement instrument; and the provision of transportation and warehousing services.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.